The reported statements, read against the company's own industry.
Financials view
Market Capitalization
592.92MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Revenue (TTM)
257.79MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Profit Margin
-7.97%
vs Health Information Services peers
Updated Sep 28, 2026
Beta
1.69x
vs all stocks
Updated Sep 28, 2026
52-Week Change
6.20%
vs all stocks
Updated Sep 28, 2026
Market Capitalization
592.92MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Enterprise Value
560.91MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Forward P/E
29.70x
vs Health Information Services peers
Updated Sep 28, 2026
Price to Sales (TTM)
2.29x
vs Health Information Services peers
Updated Sep 28, 2026
Price to Book (MRQ)
7.01x
vs Health Information Services peers
Updated Sep 28, 2026
Enterprise to Revenue
2.18x
vs Health Information Services peers
Updated Sep 28, 2026
Enterprise to EBITDA
-58.83x
vs Health Information Services peers
Updated Sep 28, 2026
Gross Margin
72.03%
vs Health Information Services peers
Updated Sep 28, 2026
Profit Margin
-7.97%
vs Health Information Services peers
Updated Sep 28, 2026
Operating Margin
-6.22%
vs Health Information Services peers
Updated Sep 28, 2026
Return on Assets (TTM)
-6.23%
vs Health Information Services peers
Updated Sep 28, 2026
Return on Equity (TTM)
-25.08%
vs Health Information Services peers
Updated Sep 28, 2026
Revenue (TTM)
257.79MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Revenue per Share (TTM)
3.29USDUpdated Sep 28, 2026
Quarterly Revenue Growth
15.50%
vs Health Information Services peers
Updated Sep 28, 2026
Gross Profit (TTM)
186.62MUSD
vs all stocks (USD)
Updated Sep 28, 2026
EBITDA (TTM)
-9.54MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Net Income (TTM)
-20.54MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Quarterly Earnings Growth (YoY)
15.52%
vs Health Information Services peers
Updated Sep 28, 2026
Operating Cash Flow (TTM)
16.85MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Levered Free Cash Flow (TTM)
39.38MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 28, 2026
Payout Ratio
0.00%
vs Health Information Services peers
Updated Sep 28, 2026
Revenue
239.02MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
66.72MUSDFY2025 · Dec 31, 2025
Gross Profit
172.31MUSDFY2025 · Dec 31, 2025
Operating Income
-30.61MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-28.98MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-924.00KUSDFY2025 · Dec 31, 2025
Net Income
-28.05MUSDFY2025 · Dec 31, 2025
EBIT
-27.28MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-10.78MUSDFY2025 · Dec 31, 2025
Research & Development
44.46MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
158.46MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.81MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.70MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-28.05MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
8.63MUSDFY2025 · Dec 31, 2025
Free Cash Flow
6.24MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
54.96MUSDFY2025 · Dec 31, 2025
Income Tax Paid
496.00KUSDFY2025 · Dec 31, 2025
Interest Paid
1.70MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-28.05MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
16.50MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
32.13MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
14.84MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-1.61MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-1.09MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-24.09MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-2.39MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-23.86MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-36.77MUSDFY2025 · Dec 31, 2025
Sale of Investments
58.46MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-4.55MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.17MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-2.89MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-10.05MUSDFY2025 · Dec 31, 2025
Shares Outstanding
79.91MSharesUpdated Sep 28, 2026
Float Shares
63.55MSharesUpdated Sep 28, 2026
Shares Short
5.11MSharesUpdated Sep 28, 2026
Short Ratio
0.9100days
vs all stocks
Updated Sep 28, 2026
Short % of Shares Outstanding
7.57%
vs all stocks
Updated Sep 28, 2026
% Held by Insiders
8.84%
vs all stocks
Updated Sep 28, 2026
% Held by Institutions
94.90%
vs all stocks
Updated Sep 28, 2026
Total Cash (MRQ)
78.47MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Cash per Share (MRQ)
0.9810USDUpdated Sep 28, 2026
Total Debt (MRQ)
51.38MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Debt to Equity (MRQ)
0.6047x
vs Health Information Services peers
Updated Sep 28, 2026
Current Ratio (MRQ)
1.25x
vs Health Information Services peers
Updated Sep 28, 2026
Book Value per Share (MRQ)
1.05USDUpdated Sep 28, 2026
Total Assets
207.97MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
104.99MUSDFY2025 · Dec 31, 2025
Total Liabilities
125.58MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
102.97MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
40.99MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
84.60MUSDFY2025 · Dec 31, 2025
Cash
19.17MUSDFY2025 · Dec 31, 2025
Cash Equivalents
35.78MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
54.96MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
26.76MUSDFY2025 · Dec 31, 2025
Accounts Receivable
4.35MUSDFY2025 · Dec 31, 2025
Accounts Payable
7.26MUSDFY2025 · Dec 31, 2025
Short-term Debt
11.36MUSDFY2025 · Dec 31, 2025
Deferred Revenue
38.05MUSDFY2025 · Dec 31, 2025
Long-term Debt
40.79MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
200.00KUSDFY2025 · Dec 31, 2025
Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025
Retained Earnings
-319.06MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
82.38MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
4.24USDUpdated Sep 28, 2026
52-Week High
7.70USDUpdated Sep 28, 2026
52-Week Change
6.20%
vs all stocks
Updated Sep 28, 2026
Beta
1.69x
vs all stocks
Updated Sep 28, 2026
50-Day MA
6.84USDUpdated Sep 28, 2026
200-Day MA
6.11USDUpdated Sep 28, 2026
Avg 10-Day Volume
1.83MSharesUpdated Sep 28, 2026
Avg 30-Day Volume
4.49MSharesUpdated Sep 28, 2026
Diluted EPS (TTM)
-0.2700USDUpdated Sep 28, 2026
Other Income / Expense
1.52MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable